Wednesday, June 16, 2021

Covid-19 vaccine Covaxin at Rs 150 not sustainable: Bharat Biotech

Higher price in private market required to offset part of the costs, argues firm

from Today's Paper https://ift.tt/2UddOND
via
By at
Labels: ,

No comments:

Post a Comment

If you have any doubts please let me know!

Subscribe to: Post Comments (Atom)

India's low score on GVC a starting point for recovery from pandemic: AIIB

India rated 7.4 percentage points below the average global value chain participation rate for emerging economies from Today's Paper ht...